FLASH radiotherapy: from preclinical promise to the first human treatment
FLASH radiotherapy – it’s the technique that’s got everyone talking. The idea is that delivering radiation at ultrahigh dose rates, roughly 50 Gy/s and above, will vastly reduce normal tissue toxicity while preserving anti-tumour activity.
The premise has been demonstrated in preclinical studies by several research groups and, as delegates at the recent AAPM Annual Meeting heard, the first human treatment has just taken place. A dedicated symposium examining the promise of FLASH saw a ballroom packed full of delegates keen to find out more about this cutting-edge treatment.